A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine
Open Access
- 5 November 2010
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 61 (1) , 54-62
Abstract
In the current study, we tested the efficacy of the mixture of naloxone, an opioid receptor antagonist, and alum, as a new adjuvant, in the inductionKeywords
This publication has 29 references indexed in Scilit:
- Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infectionMolecular and Cellular Biochemistry, 2009
- Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvantsTrends in Pharmacological Sciences, 2009
- A Reappraisal of Humoral Immunity Based on Mechanisms of Antibody‐Mediated Protection Against Intracellular Pathogens2006
- Interleukin‐1β upregulates functional expression of neurokinin‐1 receptor (NK‐1R) via NF‐κB in astrocytesGlia, 2004
- Antibody-Mediated Immunity against Intracellular Pathogens: Two-Dimensional Thinking Comes Full CircleInfection and Immunity, 2003
- Microbial Infections, Immunomodulation, and Drugs of AbuseClinical Microbiology Reviews, 2003
- Legal aspects of providing naloxone to heroin users in the United StatesInternational Journal of Drug Policy, 2001
- Contralateral but not systemic administration of the κ‐opioid agonist U‐50,488H induces anti‐nociception in acute hindpaw inflammation in ratsBritish Journal of Pharmacology, 2001
- Substance P Primes Murine Peritoneal Macrophages for an Augmented Proinflammatory Cytokine Response to LipopolysaccharideNeuroimmunomodulation, 1996
- Pretreatment with β-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized miceImmunopharmacology, 1995